Excessive sugar consumption is increasingly considered as a contributor to the emerging
epidemics of obesity and the associated cardiometabolic disease. Sugar is added to the diet …

Background Nonalcoholic fatty liver disease (NAFLD) comprises hepatic alterations with
increased lipid accumulation (steatosis) without or with inflammation (nonalcoholic …

Background & Aims Pathologists quantify liver steatosis as the fraction of lipid droplet-
containing hepatocytes out of all hepatocytes, whereas the magnetic resonance-determined …

Hepatic fibrosis is a major cause of morbidity and mortality worldwide, as it ultimately leads
to cirrhosis, which is estimated to affect up to 2% of the global population. Hepatic fibrosis is …

In recent years, there has been a plethora of attempts to discover biomarkers that are more
reliable than α-fetoprotein for the early prediction and prognosis of hepatocellular carcinoma …

Obesity is a primary antecedent to non‐alcoholic fatty liver disease whose cardinal feature is
excessive hepatic lipid accumulation. Although total hepatic lipid content closely associates …

Ingestion of titanium dioxide nanoparticles (TiO2 NPs) via dietary and environmental
exposure may pose health risks. The research about the potential effect of orally ingested …

Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as
nonalcoholic fatty liver disease, is the most prevalent liver disorder worldwide. Historically …

Abstract Non-alcoholic (now: metabolic) steatohepatitis (MASH) is the progressive
inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD) …

Hepatic fibrosis is a key pathological process of chronic liver diseases, caused by alcohol,
toxic and aberrant energy metabolism. It progresses to cirrhosis or even hepatic carcinoma …